Featured news

Alexander Pertsemlidis, Ph.D. Co-Awarded National Science Foundation Grant.

August 20, 2020

PROJECT SUMMARY Collaborative Research: Unraveling extracellular microRNA communication PI: Leonidas Bleris, Ph.D.                       Co-PI: Alexander Pertsemlidis, Ph.D. (UT Dallas)                                                   (UT Health San […]

Greehey CCRI Receives Its First NIH K99 Award (Chen Lab)

March 2, 2020

      Yu-Chiao Chiu, Ph.D., a postdoctoral researcher at the Greehey Children’s Cancer Research Institute (GCCRI), received the prestigious NIH Pathway to Independence Award (K99/R00) from the National Cancer Institute (NCI). The highly competitive NIH grant is awarded to about 30 outstanding cancer researchers nationwide each year for them to complete mentored training (K99 […]

Manjeet Rao, Ph.D. in his lab

Manjeet Rao, Ph.D., Awarded NCI, R01 Grant to Test Efficacy of Novel Drug

February 25, 2020

Dr. Manjeet Rao, Greehey CCRI Deputy Director (interim), was recently awarded a grant from National Cancer Institute ($2.1 million) to test the therapeutic efficacy of a novel drug that can inhibit the function of a protein that is highly expressed in cancers. Cancer cells use various mechanisms to manage their survival such as repairing DNA […]

Rao & Gupta

Greehey CCRI Faculty Awarded $1.2M CPRIT Grant to Support Osteosarcoma Research

February 24, 2020

Written by: Will Sansom An award of $1.2 million from the Cancer Prevention and Research Institute of Texas (CPRIT) went to Greehey CCRI Deputy Director and principal investigator Manjeet Rao, Ph.D., professor of cell systems and anatomy, for studies of an enzyme protein that helps osteosarcoma cells to survive and spread.  The team, which includes co-principal investigator Yogesh Gupta, […]

Prof. Luiz O.F. Penalva, Ph.D.

Luiz O.F. Penalva, Ph.D., Co-corresponding Senior Author on NPJ Genomic Medicine publication.

February 22, 2020

“Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles” Abstract Therapy resistance and recurrence in high-grade gliomas are driven by their populations of glioma stem cells (GSCs). Thus, detailed molecular characterization of GSCs is needed to develop more effective therapies. We conducted a study to identify differences in the splicing […]